Get Premium to unlock powerful stock data
NAS:SRPT (USA)  
Sarepta Therapeutics Inc logo

Sarepta Therapeutics Inc

$ 75.69 +0.726 (+0.97%) 03:03 PM EST
P/E:
At Loss
P/B:
7.73
Market Cap:
$ 6.62B
Enterprise V:
$ 5.68B
Volume:
535.13K
Avg Vol (2M):
768.01K
Also Trade In:
Volume:
535.13K
Market Cap $:
6.62B
PE Ratio:
At Loss
Avg Vol (2-Month):
768.01K
Enterprise Value $:
5.68B
PB Ratio:
7.73
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Sarepta Therapeutics Inc
NAICS : 325412 SIC : 2834
215 First Street, Suite 415, Cambridge, MA, USA, 02142
Description
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
Name Current Vs Industry Vs History
Cash-To-Debt 1.77
Equity-to-Asset 0.28
Debt-to-Equity 1.33
Debt-to-EBITDA -4.51
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.02
Distress
Grey
Safe
Beneish M-Score -2.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.27
9-Day RSI 59.92
14-Day RSI 57.15
6-1 Month Momentum % -19.13
12-1 Month Momentum % -6.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.56
Quick Ratio 5.13
Cash Ratio 4.43
Days Inventory 813.43
Days Sales Outstanding 69.14
Days Payable 225.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-08-04 Est.)

SRPT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:SRPT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 765.786
EPS (TTM) ($) -4.25
Beta 1.18
Volatility % 41.98
14-Day RSI 57.15
14-Day ATR ($) 3.533038
20-Day SMA ($) 70.6045
12-1 Month Momentum % -6.33
52-Week Range ($) 61.28 - 101.24
Shares Outstanding (Mil) 87.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sarepta Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More